Cargando…

Pharmacokinetics of doxorubicin co-administered with high-dose verapamil.

The potential for the modification of the pharmacokinetics of doxorubicin (DOX) concurrently administered with high-dose verapamil (VER) has been investigated in 17 patients with advanced neoplasms refractory to drugs belonging to the multidrug resistance spectrum. Steady-state concentration of DOX,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gigante, M., Toffoli, G., Boiocchi, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033454/ https://www.ncbi.nlm.nih.gov/pubmed/7819028

Ejemplares similares

Phase I and pharmacokinetic study of D-verapamil and doxorubicin.
por: Bissett, D., et al.
Publicado: (1991)

Influence of verapamil on the pharmacokinetics of oridonin in rats
por: Liu, Jing, et al.
Publicado: (2019)

Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposide.
por: Toffoli, G., et al.
Publicado: (1997)

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Kim, Minsoo, et al.
Publicado: (2019)

Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism
por: Xing, Hua, et al.
Publicado: (2020)

Pharmacokinetic Interaction between Metformin and Verapamil in Rats: Inhibition of the OCT2-Mediated Renal Excretion of Metformin by Verapamil
por: Han, Seung Yon, et al.
Publicado: (2020)

Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988)

Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
por: Scheithauer, W., et al.
Publicado: (1993)

Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism
por: Shang, Haihua, et al.
Publicado: (2021)

CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma
por: Zhang, Tengyue, et al.
Publicado: (2017)

New recipes for old ingredients: high doses of methylprednisolone and verapamil in cluster headache
por: Zanchin, G, et al.
Publicado: (2013)

Pharmacokinetics of orally administered single‐dose ponazuril in cats
por: Burlison, Catherine, et al.
Publicado: (2022)

Verapamil in Diabetes
por: Poudel, Resham Raj, et al.
Publicado: (2017)

Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study
por: Zhu, Junfeng, et al.
Publicado: (2023)

The Effect of Low Dose Sildenafil On Verapamil - Induced Cardiovascular Toxicity in Rats
por: Gul, F, et al.
Publicado: (2015)

Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.
por: Toffoli, G., et al.
Publicado: (1991)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
por: Lim, Seula, et al.
Publicado: (2019)

Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day)
por: Lanteri-Minet, M., et al.
Publicado: (2011)

Dose-Dependent Response to Cyclodextrin Infusion in a Rat Model of Verapamil Toxicity
por: Mottram, Allan R, et al.
Publicado: (2012)

Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022)

Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients
por: Kouanda, Seni, et al.
Publicado: (2020)

Pharmacokinetic Modeling of (R)-[(11)C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates
por: García-Varela, Lara, et al.
Publicado: (2020)

Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
por: Li, Yingxin, et al.
Publicado: (2023)

Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022)

A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2023)

Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support.
por: van Warmerdam, L. J., et al.
Publicado: (1996)

Pharmacokinetics of Orally Administered Prednisolone in Alpacas
por: Videla, Ricardo, et al.
Publicado: (2021)

High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?
por: Alexandre, Joachim, et al.
Publicado: (2015)

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
por: De Gregori, Simona, et al.
Publicado: (2023)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Pharmacokinetic Parameters and Tissue Withdrawal Intervals for Sheep Administered Multiple Oral Doses of Meloxicam
por: Depenbrock, Sarah, et al.
Publicado: (2021)

Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
por: Teng, Renli, et al.
Publicado: (2013)

Population pharmacokinetic analysis of metformin administered as fixed-dose combination in Korean healthy adults
por: Choi, Suein, et al.
Publicado: (2018)

Pharmacokinetic interaction between verapamil and ritonavir-boosted nirmatrelvir: implications for the management of COVID-19 in patients with hypertension
por: Haque, Obaid Imtiyazul, et al.
Publicado: (2023)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d’Ivoire
por: Edi, Constant, et al.
Publicado: (2019)

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
por: Kip, Anke E., et al.
Publicado: (2017)

Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
por: Gossner, L., et al.
Publicado: (1991)

Late morfofunctional alterations of the Sertoli cell caused by doxorubicin administered to prepubertal rats
por: Brilhante, Otávio, et al.
Publicado: (2012)

Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia
por: Kitoh, Hiroshi, et al.
Publicado: (2020)

Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
por: Cowie, F. J., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_oo8dsuco48ea20u5q7jfga3ric